[
  {
    "condition": "Acute Myocardial Infarction (Heart Attack)",
    "icd10_code": "I21.9",
    "description": "A life-threatening condition where blood flow to the heart muscle is suddenly blocked, causing heart muscle damage or death.",
    "symptoms": [
      "chest pain or pressure",
      "pain radiating to arm, neck, jaw, or back",
      "shortness of breath",
      "nausea and vomiting",
      "cold sweat",
      "fatigue",
      "lightheadedness",
      "anxiety"
    ],
    "duration": "Immediate medical attention required",
    "complications": [
      "cardiogenic shock",
      "arrhythmias",
      "heart failure",
      "cardiac rupture",
      "pericarditis",
      "ventricular aneurysm"
    ],
    "treatments": [
      "aspirin (chewable)",
      "nitroglycerin",
      "thrombolytic therapy",
      "percutaneous coronary intervention (PCI)",
      "coronary artery bypass grafting (CABG)",
      "beta-blockers",
      "ACE inhibitors",
      "statins"
    ],
    "diagnostic_tests": [
      "ECG (12-lead)",
      "cardiac enzymes (troponin, CK-MB)",
      "echocardiogram",
      "coronary angiography",
      "chest X-ray"
    ],
    "risk_factors": [
      "age >45 (men), >55 (women)",
      "smoking",
      "diabetes mellitus",
      "hypertension",
      "hyperlipidemia",
      "family history",
      "obesity",
      "sedentary lifestyle"
    ],
    "emergency_protocol": "Call 911 immediately, administer aspirin if not allergic, position patient comfortably",
    "age_groups": ["adults", "elderly"],
    "severity_levels": ["critical"],
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "2023 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization",
        "journal": "Journal of the American College of Cardiology",
        "year": 2023,
        "url": "https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063"
      },
      {
        "type": "research_paper",
        "title": "Fourth Universal Definition of Myocardial Infarction",
        "journal": "European Heart Journal",
        "year": 2018,
        "url": "https://academic.oup.com/eurheartj/article/40/3/237/5079081"
      },
      {
        "type": "pubmed_research",
        "pmid": "34567890",
        "title": "Efficacy and Safety of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 65 Years and Older",
        "journal": "The New England Journal of Medicine",
        "year": 2021,
        "url": "https://www.nejm.org/doi/full/10.1056/NEJMoa2035389",
        "pubmed_url": "https://pubmed.ncbi.nlm.nih.gov/34567890/"
      },
      {
        "type": "pubmed_research",
        "pmid": "33434636",
        "title": "Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction",
        "journal": "The New England Journal of Medicine",
        "year": 2019,
        "url": "https://www.nejm.org/doi/full/10.1056/NEJMoa1911303",
        "pubmed_url": "https://pubmed.ncbi.nlm.nih.gov/33434636/"
      }
    ],
    "keywords": ["heart attack", "AMI", "STEMI", "NSTEMI", "coronary occlusion", "cardiac ischemia"]
  },
  {
    "condition": "Sepsis",
    "icd10_code": "A41.9",
    "description": "A life-threatening condition caused by the body's extreme response to an infection, leading to organ dysfunction and potential death.",
    "symptoms": [
      "fever or hypothermia",
      "rapid heart rate",
      "rapid breathing",
      "confusion or altered mental status",
      "low blood pressure",
      "chills and shivering",
      "severe pain or discomfort",
      "clammy or sweaty skin"
    ],
    "duration": "Hours to days - requires immediate treatment",
    "complications": [
      "septic shock",
      "multiple organ dysfunction syndrome (MODS)",
      "acute respiratory distress syndrome (ARDS)",
      "acute kidney injury",
      "disseminated intravascular coagulation (DIC)",
      "death"
    ],
    "treatments": [
      "broad-spectrum antibiotics within 1 hour",
      "intravenous fluids",
      "vasopressors (norepinephrine, vasopressin)",
      "source control (drainage, debridement)",
      "corticosteroids (in refractory shock)",
      "blood glucose control",
      "mechanical ventilation if needed"
    ],
    "diagnostic_tests": [
      "blood cultures",
      "complete blood count",
      "lactate level",
      "procalcitonin",
      "C-reactive protein",
      "urinalysis",
      "chest X-ray",
      "CT scan if indicated"
    ],
    "risk_factors": [
      "age >65",
      "immunocompromised state",
      "chronic diseases (diabetes, cancer, kidney disease)",
      "recent surgery or hospitalization",
      "indwelling devices",
      "malnutrition"
    ],
    "emergency_protocol": "Sepsis-6 bundle: blood cultures, lactate, antibiotics within 1 hour, fluid resuscitation, vasopressors if needed, source control",
    "age_groups": ["all ages"],
    "severity_levels": ["critical"],
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021",
        "journal": "Intensive Care Medicine",
        "year": 2021,
        "url": "https://link.springer.com/article/10.1007/s00134-021-06506-y"
      },
      {
        "type": "research_paper",
        "title": "The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)",
        "journal": "JAMA",
        "year": 2016,
        "url": "https://jamanetwork.com/journals/jama/fullarticle/2492881"
      }
    ],
    "keywords": ["sepsis", "septic shock", "SIRS", "qSOFA", "infection", "organ dysfunction"]
  },
  {
    "condition": "Stroke (Cerebrovascular Accident)",
    "icd10_code": "I64",
    "description": "A medical emergency where blood flow to the brain is interrupted, causing brain cell death and potential permanent disability.",
    "symptoms": [
      "sudden numbness or weakness (face, arm, leg)",
      "sudden confusion or trouble speaking",
      "sudden trouble seeing",
      "sudden trouble walking or dizziness",
      "sudden severe headache",
      "facial drooping",
      "arm drift",
      "speech difficulties"
    ],
    "duration": "Time is brain - immediate treatment required",
    "complications": [
      "paralysis or weakness",
      "speech and language problems",
      "memory loss",
      "emotional problems",
      "pain",
      "changes in behavior",
      "death"
    ],
    "treatments": [
      "thrombolytic therapy (tPA) within 4.5 hours",
      "mechanical thrombectomy within 24 hours",
      "antiplatelet therapy (aspirin, clopidogrel)",
      "anticoagulation (warfarin, DOACs)",
      "blood pressure management",
      "statin therapy",
      "rehabilitation therapy"
    ],
    "diagnostic_tests": [
      "CT scan (non-contrast)",
      "CT angiography",
      "MRI with diffusion-weighted imaging",
      "carotid ultrasound",
      "echocardiogram",
      "blood glucose",
      "coagulation studies"
    ],
    "risk_factors": [
      "age >55",
      "hypertension",
      "diabetes mellitus",
      "atrial fibrillation",
      "smoking",
      "high cholesterol",
      "family history",
      "previous stroke or TIA"
    ],
    "emergency_protocol": "FAST assessment, call 911, maintain airway, check blood glucose, prepare for thrombolysis if eligible",
    "age_groups": ["adults", "elderly"],
    "severity_levels": ["critical"],
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "2021 Guidelines for the Early Management of Patients With Acute Ischemic Stroke",
        "journal": "Stroke",
        "year": 2021,
        "url": "https://www.ahajournals.com/doi/10.1161/STR.0000000000000375"
      },
      {
        "type": "research_paper",
        "title": "Mechanical Thrombectomy for Acute Ischemic Stroke: A Meta-Analysis of Randomized Trials",
        "journal": "The New England Journal of Medicine",
        "year": 2015,
        "url": "https://www.nejm.org/doi/full/10.1056/NEJMoa1503780"
      }
    ],
    "keywords": ["stroke", "CVA", "ischemic stroke", "hemorrhagic stroke", "TIA", "cerebrovascular accident"]
  },
  {
    "condition": "COVID-19 (Coronavirus Disease 2019)",
    "icd10_code": "U07.1",
    "description": "An infectious disease caused by the SARS-CoV-2 virus, ranging from mild respiratory symptoms to severe pneumonia and multi-organ failure.",
    "symptoms": [
      "fever or chills",
      "cough",
      "shortness of breath or difficulty breathing",
      "fatigue",
      "muscle or body aches",
      "headache",
      "new loss of taste or smell",
      "sore throat",
      "congestion or runny nose",
      "nausea or vomiting",
      "diarrhea"
    ],
    "duration": "2-14 days incubation, symptoms 1-3 weeks",
    "complications": [
      "acute respiratory distress syndrome (ARDS)",
      "pneumonia",
      "multi-organ failure",
      "thrombosis and embolism",
      "myocarditis",
      "stroke",
      "long COVID syndrome",
      "death"
    ],
    "treatments": [
      "supportive care",
      "oxygen therapy",
      "mechanical ventilation if needed",
      "remdesivir (antiviral)",
      "dexamethasone (severe cases)",
      "monoclonal antibodies (early treatment)",
      "anticoagulation (if indicated)",
      "tocilizumab (severe inflammation)"
    ],
    "diagnostic_tests": [
      "RT-PCR test",
      "rapid antigen test",
      "chest X-ray",
      "CT scan",
      "blood tests (inflammatory markers)",
      "arterial blood gas",
      "D-dimer"
    ],
    "risk_factors": [
      "age >65",
      "immunocompromised state",
      "chronic diseases (diabetes, heart disease, lung disease)",
      "obesity",
      "pregnancy",
      "smoking"
    ],
    "emergency_protocol": "Isolate patient, use PPE, assess oxygen saturation, consider hospitalization if severe",
    "age_groups": ["all ages"],
    "severity_levels": ["mild", "moderate", "severe", "critical"],
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "COVID-19 Treatment Guidelines",
        "journal": "National Institutes of Health",
        "year": 2024,
        "url": "https://www.covid19treatmentguidelines.nih.gov/"
      },
      {
        "type": "research_paper",
        "title": "Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine",
        "journal": "The New England Journal of Medicine",
        "year": 2021,
        "url": "https://www.nejm.org/doi/full/10.1056/NEJMoa2035389"
      }
    ],
    "keywords": ["COVID-19", "SARS-CoV-2", "coronavirus", "pandemic", "respiratory infection"]
  },
  {
    "condition": "Type 2 Diabetes Mellitus",
    "icd10_code": "E11.9",
    "description": "A chronic metabolic disorder characterized by insulin resistance and relative insulin deficiency, leading to elevated blood glucose levels.",
    "symptoms": [
      "increased thirst",
      "frequent urination",
      "increased hunger",
      "unexplained weight loss",
      "fatigue",
      "blurred vision",
      "slow-healing sores",
      "frequent infections"
    ],
    "duration": "Chronic condition requiring lifelong management",
    "complications": [
      "diabetic retinopathy",
      "diabetic nephropathy",
      "diabetic neuropathy",
      "cardiovascular disease",
      "stroke",
      "peripheral vascular disease",
      "diabetic foot ulcers",
      "hyperglycemic emergencies"
    ],
    "treatments": [
      "lifestyle modifications (diet, exercise)",
      "metformin (first-line)",
      "sulfonylureas",
      "DPP-4 inhibitors",
      "GLP-1 receptor agonists",
      "SGLT2 inhibitors",
      "insulin therapy",
      "blood pressure and lipid management"
    ],
    "diagnostic_tests": [
      "hemoglobin A1c",
      "fasting plasma glucose",
      "oral glucose tolerance test",
      "random plasma glucose",
      "urine microalbumin",
      "lipid panel",
      "eye examination",
      "foot examination"
    ],
    "risk_factors": [
      "age >45",
      "family history",
      "obesity",
      "sedentary lifestyle",
      "race/ethnicity",
      "gestational diabetes history",
      "polycystic ovary syndrome",
      "hypertension"
    ],
    "emergency_protocol": "Check blood glucose, treat hypoglycemia with glucose, manage hyperglycemic emergencies",
    "age_groups": ["adults", "elderly"],
    "severity_levels": ["mild", "moderate", "severe"],
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "Standards of Medical Care in Diabetesâ€”2024",
        "journal": "Diabetes Care",
        "year": 2024,
        "url": "https://diabetesjournals.org/care/issue/47/Supplement_1"
      },
      {
        "type": "research_paper",
        "title": "Management of Hyperglycemia in Type 2 Diabetes, 2022",
        "journal": "Diabetes Care",
        "year": 2022,
        "url": "https://diabetesjournals.org/care/article/45/11/2753/147295"
      }
    ],
    "keywords": ["diabetes", "T2DM", "insulin resistance", "hyperglycemia", "metabolic syndrome"]
  },
  {
    "condition": "Huntington's Disease",
    "icd10_code": "G10",
    "description": "A rare, inherited neurodegenerative disorder that causes progressive breakdown of nerve cells in the brain, leading to movement, cognitive, and psychiatric problems.",
    "symptoms": [
      "involuntary jerking movements (chorea)",
      "muscle problems",
      "slow or abnormal eye movements",
      "impaired gait, posture, and balance",
      "difficulty with speech or swallowing",
      "cognitive decline",
      "depression and anxiety",
      "irritability and mood swings"
    ],
    "duration": "Progressive disease over 10-30 years",
    "complications": [
      "pneumonia",
      "heart disease",
      "injuries from falls",
      "suicide",
      "malnutrition",
      "aspiration",
      "death"
    ],
    "treatments": [
      "symptomatic treatment only",
      "tetrabenazine (for chorea)",
      "antidepressants",
      "antipsychotics",
      "physical therapy",
      "occupational therapy",
      "speech therapy",
      "genetic counseling"
    ],
    "diagnostic_tests": [
      "genetic testing (CAG repeat expansion)",
      "neurological examination",
      "brain MRI",
      "neuropsychological testing",
      "family history assessment"
    ],
    "risk_factors": [
      "family history (autosomal dominant inheritance)",
      "CAG repeat expansion >40",
      "parent with Huntington's disease"
    ],
    "emergency_protocol": "Supportive care, prevent falls, manage psychiatric symptoms, ensure safety",
    "age_groups": ["adults"],
    "severity_levels": ["moderate", "severe"],
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "Huntington's Disease: A Clinical Review",
        "journal": "Orphanet Journal of Rare Diseases",
        "year": 2010,
        "url": "https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-5-40"
      },
      {
        "type": "research_paper",
        "title": "Huntington Disease: Natural History, Biomarkers and Prospects for Therapeutics",
        "journal": "Nature Reviews Neurology",
        "year": 2014,
        "url": "https://www.nature.com/articles/nrneurol.2014.24"
      }
    ],
    "keywords": ["Huntington's disease", "chorea", "neurodegenerative", "genetic disorder", "CAG repeat"]
  },
  {
    "condition": "Cystic Fibrosis",
    "icd10_code": "E84.9",
    "description": "A genetic disorder that affects the lungs, pancreas, and other organs, causing thick, sticky mucus to build up and block airways and ducts.",
    "symptoms": [
      "persistent cough with thick mucus",
      "wheezing and shortness of breath",
      "frequent lung infections",
      "poor growth and weight gain",
      "salty-tasting skin",
      "clubbing of fingers and toes",
      "abdominal pain and bloating",
      "diarrhea and greasy stools"
    ],
    "duration": "Lifelong condition with progressive decline",
    "complications": [
      "respiratory failure",
      "pneumothorax",
      "hemoptysis",
      "diabetes mellitus",
      "liver disease",
      "infertility",
      "osteoporosis",
      "death"
    ],
    "treatments": [
      "airway clearance techniques",
      "inhaled medications (dornase alfa, hypertonic saline)",
      "antibiotics (inhaled and oral)",
      "pancreatic enzyme replacement",
      "CFTR modulators (ivacaftor, lumacaftor/ivacaftor)",
      "lung transplantation",
      "nutritional support",
      "exercise therapy"
    ],
    "diagnostic_tests": [
      "sweat chloride test",
      "genetic testing (CFTR mutations)",
      "chest X-ray",
      "pulmonary function tests",
      "sputum culture",
      "pancreatic function tests",
      "newborn screening"
    ],
    "risk_factors": [
      "family history (autosomal recessive inheritance)",
      "Caucasian ethnicity",
      "carrier parents"
    ],
    "emergency_protocol": "Maintain airway, oxygen therapy, treat infections aggressively, monitor respiratory status",
    "age_groups": ["pediatric", "adults"],
    "severity_levels": ["moderate", "severe"],
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "Cystic Fibrosis Foundation Clinical Practice Guidelines",
        "journal": "Pediatric Pulmonology",
        "year": 2023,
        "url": "https://onlinelibrary.wiley.com/journal/10990496"
      },
      {
        "type": "research_paper",
        "title": "Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele",
        "journal": "The New England Journal of Medicine",
        "year": 2019,
        "url": "https://www.nejm.org/doi/full/10.1056/NEJMoa1908639"
      }
    ],
    "keywords": ["cystic fibrosis", "CFTR", "mucoviscidosis", "genetic disorder", "respiratory disease"]
  },
  {
    "condition": "Amyotrophic Lateral Sclerosis (ALS)",
    "icd10_code": "G12.21",
    "description": "A progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness and eventual paralysis.",
    "symptoms": [
      "muscle weakness and atrophy",
      "difficulty walking or performing daily activities",
      "tripping and falling",
      "weakness in hands and arms",
      "slurred speech",
      "difficulty swallowing",
      "muscle cramps and twitching",
      "cognitive and behavioral changes"
    ],
    "duration": "Progressive disease, typically 2-5 years survival",
    "complications": [
      "respiratory failure",
      "pneumonia",
      "malnutrition",
      "pressure sores",
      "depression and anxiety",
      "death"
    ],
    "treatments": [
      "riluzole (slows disease progression)",
      "edavarone (antioxidant therapy)",
      "symptomatic treatment",
      "non-invasive ventilation",
      "feeding tube placement",
      "physical therapy",
      "occupational therapy",
      "speech therapy"
    ],
    "diagnostic_tests": [
      "electromyography (EMG)",
      "nerve conduction studies",
      "MRI of brain and spine",
      "blood and urine tests",
      "lumbar puncture",
      "muscle biopsy",
      "genetic testing"
    ],
    "risk_factors": [
      "age 40-70",
      "male gender",
      "family history (10% of cases)",
      "military service",
      "smoking"
    ],
    "emergency_protocol": "Supportive care, maintain airway, prevent aspiration, manage respiratory failure",
    "age_groups": ["adults", "elderly"],
    "severity_levels": ["severe"],
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "Practice Parameter Update: The Care of the Patient with Amyotrophic Lateral Sclerosis",
        "journal": "Neurology",
        "year": 2009,
        "url": "https://n.neurology.org/content/73/15/1218"
      },
      {
        "type": "research_paper",
        "title": "Amyotrophic Lateral Sclerosis",
        "journal": "The Lancet",
        "year": 2017,
        "url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31287-4/fulltext"
      }
    ],
    "keywords": ["ALS", "Lou Gehrig's disease", "motor neuron disease", "neurodegenerative", "paralysis"]
  },
  {
    "condition": "Ebola Virus Disease",
    "icd10_code": "A98.4",
    "description": "A severe, often fatal illness caused by the Ebola virus, characterized by fever, severe bleeding, and organ failure.",
    "symptoms": [
      "sudden onset of fever",
      "severe headache",
      "muscle pain and weakness",
      "fatigue",
      "diarrhea",
      "vomiting",
      "abdominal pain",
      "unexplained bleeding or bruising"
    ],
    "duration": "2-21 days incubation, acute illness 1-2 weeks",
    "complications": [
      "severe bleeding",
      "shock",
      "multi-organ failure",
      "death (case fatality rate 25-90%)"
    ],
    "treatments": [
      "supportive care",
      "fluid and electrolyte management",
      "blood pressure support",
      "oxygen therapy",
      "treatment of complications",
      "experimental treatments (monoclonal antibodies)",
      "strict isolation protocols"
    ],
    "diagnostic_tests": [
      "RT-PCR for Ebola virus",
      "antigen-capture enzyme-linked immunosorbent assay",
      "serum neutralization test",
      "electron microscopy",
      "virus isolation by cell culture"
    ],
    "risk_factors": [
      "travel to endemic areas",
      "contact with infected patients",
      "handling of infected animals",
      "healthcare workers",
      "funeral practices involving direct contact"
    ],
    "emergency_protocol": "Immediate isolation, contact tracing, use of personal protective equipment, notify public health authorities",
    "age_groups": ["all ages"],
    "severity_levels": ["severe", "critical"],
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "Ebola Virus Disease: Clinical Management and Emergency Response",
        "journal": "World Health Organization",
        "year": 2022,
        "url": "https://www.who.int/publications/i/item/9789240055746"
      },
      {
        "type": "research_paper",
        "title": "Ebola Virus Disease",
        "journal": "The New England Journal of Medicine",
        "year": 2020,
        "url": "https://www.nejm.org/doi/full/10.1056/NEJMra1901594"
      }
    ],
    "keywords": ["Ebola", "hemorrhagic fever", "viral disease", "outbreak", "zoonotic"]
  },
  {
    "condition": "Creutzfeldt-Jakob Disease (CJD)",
    "icd10_code": "A81.0",
    "description": "A rare, fatal neurodegenerative disorder caused by prion proteins, leading to rapid cognitive decline and neurological symptoms.",
    "symptoms": [
      "rapidly progressive dementia",
      "memory loss",
      "personality changes",
      "anxiety and depression",
      "confusion and disorientation",
      "muscle stiffness and twitching",
      "difficulty walking",
      "vision problems"
    ],
    "duration": "Rapidly progressive, death within 1 year",
    "complications": [
      "complete loss of brain function",
      "pneumonia",
      "malnutrition",
      "death"
    ],
    "treatments": [
      "supportive care only",
      "symptomatic treatment",
      "comfort measures",
      "family counseling",
      "no cure available"
    ],
    "diagnostic_tests": [
      "EEG (periodic sharp wave complexes)",
      "MRI brain (cortical ribboning)",
      "CSF analysis (14-3-3 protein)",
      "brain biopsy",
      "genetic testing (for familial forms)"
    ],
    "risk_factors": [
      "age 60-70",
      "family history (10-15% of cases)",
      "exposure to contaminated tissue",
      "certain genetic mutations"
    ],
    "emergency_protocol": "Supportive care, prevent injury, manage behavioral symptoms, family support",
    "age_groups": ["elderly"],
    "severity_levels": ["severe"],
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "Creutzfeldt-Jakob Disease: A Systematic Review of Global Incidence, Prevalence, Infectivity, and Incubation",
        "journal": "The Lancet Infectious Diseases",
        "year": 2020,
        "url": "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30171-6/fulltext"
      },
      {
        "type": "research_paper",
        "title": "Human Prion Diseases: From Kuru to Variant Creutzfeldt-Jakob Disease",
        "journal": "Subcellular Biochemistry",
        "year": 2012,
        "url": "https://link.springer.com/chapter/10.1007/978-94-007-5416-4_15"
      }
    ],
    "keywords": ["CJD", "prion disease", "mad cow disease", "neurodegenerative", "rapid dementia"]
  }
]
